#15 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Even if the CBD gummy in your hand is legal, the liquid used to manufacture it may not be—meaning American CBD production could be forced offshore or shut down entirely.
Adam Terry, CEO of hemp beverage company Cantrip, explains a critical flaw: even if individually wrapped gummies could contain 0.4mg THC, the liquid used to make the molds would exceed the container limit on intermediates—making them illegal to manufacture in the US. The intermediate product rule means CBD crude and distillate routinely exceed 0.3% total THC during processing, even when the final product is non-intoxicating. Full-spectrum CBD needs comprehensive reform.
“This is the most underreported crisis in the entire hemp debate: the law makes it legal to sell CBD but potentially illegal to make it, which is regulatory absurdity of the highest order.”
THE INTERMEDIATE PRODUCT TRAP: HOW THE HEMP BAN KILLS CBD MANUFACTURING
Most coverage of the November hemp ban focuses on final products—gummies, seltzers, tinctures. But the real threat to American CBD manufacturing is hiding in the fine print: the intermediate product rule.
Here’s the problem. During extraction and refinement, virtually all CBD crude and distillate routinely exceeds 0.3% total THC on a weight basis, even when the final bottled product falls well below the limit. Under the new law, those intermediate materials are no longer hemp. They’re controlled substances.
As industry analyst Deb Tharp explained it: ‘Your stainless steel tank on the way there is suddenly on the wrong side of federal law.’ Even if your end product is non-intoxicating CBD, the stuff you’re processing is now illegal.
Adam Terry, CEO of hemp beverage company Cantrip, drives the point home with a specific example: even if individually wrapped gummies could contain 0.4mg THC each, the liquid used to pour into molds would exceed the container limit. Result: legal to sell, illegal to make.
This isn’t a hypothetical edge case. It’s the fundamental economics of CBD extraction. Full-spectrum CBD production requires intermediate steps that will, by definition, violate the new law. Without comprehensive reform, American CBD manufacturing may be forced offshore.
Have thoughts on this? Share it:
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →